The Montgomery Advertiser on MSN2d
HIV stigma is on the decline for the first time in five years, new study findsHIV stigma, for the first time in five years, is on the decline in the United States, despite knowledge gaps in certain ...
First Opinion readers on clinical trials in Africa, compounded semaglutide, depressed mice, and more
First Opinion is STAT’s platform for interesting, illuminating, and provocative articles about the life sciences writ large, ...
Metformin, a common medication used to treat type 2 diabetes, may also help reduce the viral reservoir in people living with ...
Insomnia and chronic pain are common symptoms in people with HIV. Poor sleep has been associated with chronic pain. While cognitive behavioral therapy for insomnia improves insomnia in clinical ...
The future of CRISPR involves clinical trials focused on treatment for blood diseases and cancers, cardiovascular disease, ...
News Medical on MSN4d
New study increases understanding of HIV drug’s negative effects on the brainEfavirenz is an important drug for treating HIV infection, but it causes negative neuropsychiatric effects in roughly 50% of ...
The largest-ever study of women in sub-Saharan Africa zeroes in on the combination of bacterial vaginosis-associated bacteria ...
healthday on MSN9d
Twice-Yearly Injection Cuts HIV Risk by 96%, But Will Cost Cut Access?It could be a real breakthrough for people at risk for HIV infection: A shot given every six months that reduces th ...
It wasn't that long ago when an HIV diagnosis was essentially a death sentence. When the disease was running rampant in the 80's and 90's, treatment options ...
Proof-of-Concept Study to Find Functional Cure for HIV July 24, 2024 — Researchers conducted a breakthrough proof-of-concept study that found an HIV-like virus particle that could cease the need ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback